Table 13 Univariable and multivariable binary logistic regression analysis of predictors of dosing problems
Variable | Univariable analysis | P-Value | Multivariable analysis | P-value |
|---|---|---|---|---|
COR (95% CI) | AOR (95% CI) | |||
Age (years) | ||||
 29–39 | 1 |  | 1 |  |
 40–50 | 1.7(0.34–8.15) | 0.529 | 2.4(0.32–17.61) | 0.412 |
  ≥ 51 | 1.5(0.32–6.39) | 0.625 | 1.7(0.24–11.52) |  |
Education | ||||
 Illiterate | 1 |  | 1 |  |
 Literate | 2.8(0.54–14.11) | 0.221 | 4.2(0.60–30.01) | 0.161 |
Marital status | ||||
 Single | 1 |  | 1 |  |
 Married | 1.6(0.54–4.82) | 0.386 | 1.2(0.42–3.71) | 0.761 |
Co-morbidity | ||||
 No | 1 |  | 1 |  |
 Yes | 0.4(0.17–1.11) | 0.084 | 0.4(0.11–1.32) | 0.125 |
Number of medications | ||||
  < 5 | 1 |  | 1 |  |
  ≥ 5 | 3.2(1.15–8.73) | 0.026* | 3.6(1.24–11.23) | 0.026* |
Type of cancer | ||||
 Adenocarcinoma & Invasive anaplastic carcinoma | 1 |  | 1 |  |
 Squamous cell carcinoma | 1.6(0.29–8.96) | 0.586 | 1.5(0.32–7.43) | 0.614 |
 Stage of cervical cancer |  |  |  |  |
 Early stage | 1 |  | 1 |  |
 Advanced stage | 2.3(0.58–9.33) | 0.231 | 3.2(0.72–13.62) | 0.121 |
Treatment Regimen | ||||
 Cisplatin + Paclitaxel | 3.7(0.9–16.5) | 0.079 | 9.8(1.25–77.81) | 0.030* |